LifeTech Scientific (HKG:1302) booked 147.8 million yuan in attributable profit for 2025, down 34% from 222.4 million yuan in 2024, according to a Hong Kong bourse filing Tuesday.
Earnings per share were 0.033 yuan, compared with 0.051 yuan in the prior year.
Revenue rose 5.1% year on year to 1.37 billion yuan, figures showed.
The firm did not declare a final dividend for the year.
Shares of the company were down nearly 3% in recent trade.